Aaron Cox new CFO of Galapagos
24-06-2025 Galapagos has announced the appointment of Aaron Cox as Chief Financial Officer, effective 7 July 2025. He will succeed Thad Huston, who will remain with the company until 31 July to ensure a smooth transition.
Aaron Cox brings over twenty years of leadership experience in biotechnology, capital markets, mergers and acquisitions, and corporate development. Prior to his appointment, he served as Executive Vice President and Chief Financial Officer at Horizon Therapeutics plc. Before that, he held the roles of Head of Corporate Development and Chief of Staff to the CEO at the same company. Earlier in his career, he held senior positions in the investment banking sector.
Henry Gosebruch, CEO of Galapagos, expressed his enthusiasm about Cox’s arrival: “Aaron Cox will be a key partner in accelerating the growth of our pipeline through business development and in deploying our resources effectively through disciplined financial management. His experience as a dealmaker and as a leader of a global finance organization makes him an invaluable asset to Galapagos as we continue our transformation with the goal of making a meaningful impact on the lives of patients around the world.”